Article Date: 08 Dec 2011 - 2:00 PST
email to a friend 
printer friendly 
opinions 
Hispanic women are more likely to die from breast cancer than non-Hispanic white women, according to research presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.
"This difference may be associated with a tumor phenotype that is less responsive to chemotherapy," said Kathy B. Baumgartner, Ph.D., professor of epidemiology and associate dean for faculty affairs in the School of Public Health and Information Sciences at the University of Louisville in Kentucky. "Increased awareness of this ethnic disparity is needed to improve survival in Hispanic women with breast cancer."
Breast cancer is the most common cancer and is the second cause of cancer death in women in the United States. Incidence and survival rates vary by ethnicity, and previous research has demonstrated a trend toward poorer survival in Hispanic women.
From 1992 to 1996, Baumgartner and colleagues conducted the New Mexico Women's Health Study (NMWHS), a statewide, population-based, case-control breast cancer study that examined the difference between Hispanic and non-Hispanic white women for breast cancer risk. In all, 692 women with a first primary breast cancer participated.
In a recent study, researchers followed the 577 women with invasive breast cancer through 2008 to assess differences in long-term survival between Hispanic and non-Hispanic white women in the NMWHS.
Hispanic women were about 20 percent more likely to die from breast cancer than non-Hispanic white women, which is consistent with other reports, Baumgartner said. After adjusting for age, stage, lymph node involvement and estrogen receptor (ER) status, the researchers saw the risk drop considerably to almost equal that of non-Hispanic white women suggesting that "the ethnic difference in breast cancer mortality may be mostly biologically based," Baumgartner said.
In addition, Hispanic women who received chemotherapy were about 1.5 times more likely to die from breast cancer compared with non-Hispanic white women who received chemotherapy, after adjusting for age and the characteristics noted above.
"It is not clear how much of this ethnic difference in survival is due to socioeconomic factors influencing access to screening and treatment or to biological ones," Baumgartner said. "Some studies suggest that Hispanic women are more likely to develop ER-negative tumors that are resistant to chemotherapy."
She added, "Altered response to chemotherapy may partly explain the Hispanic vs. non-Hispanic white disparity in breast cancer survival."
There was no difference between Hispanic and non-Hispanic white women for all-cause or non-breast cancer mortality.
Baumgartner and her colleagues will continue to monitor this cohort for the long term. This research was supported by a grant from the National Cancer Institute and the James Graham Brown Cancer Center.
Article adapted by Medical News Today from original press release. Source: American Association for Cancer ResearchVisit our breast cancer section for the latest news on this subject. American Association for Cancer Research Please use one of the following formats to cite this article in your essay, paper or report:
MLA
8 Dec. 2011.
Please note: If no author information is provided, the source is cited instead.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
